Showing results (71-80 of 651) with videos related to

Sort By:
Pageof 66
European Journal of Cancer (Oxford, England : 1990)|July 14, 2023
A demand-offer critical analysis of current drug development. Phase I drugs versus TCGA sequencing dataMatteo Repetto, Edoardo Crimini, Carmen Belli, et al.
Oncoscience|August 6, 2015
Challenges and perspective of drug repurposing strategies in early phase clinical trialsShumei Kato, Stacy L Moulder, Naoto T Ueno, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|February 27, 2015
Adapting a natural language processing tool to facilitate clinical trial curation for personalized cancer therapyJia Zeng, Yonghui Wu, Ann Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cellsWallace H Mondesire, Weiguo Jian, Haixia Zhang, et al.
Molecular Cancer Therapeutics|July 23, 2008
eIF4E knockdown decreases breast cancer cell growth without activating Akt signalingAlpana Soni, Argun Akcakanat, Gopal Singh, et al.
American Journal of Surgery|September 17, 2005
Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel nodeNazanin Khakpour, Kelly K Hunt, Henry M Kuerer, et al.
BMC Cancer|April 16, 2008
Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndromeLarissa I Batista, Karen H Lu, Elisabeth K Beahm, et al.
The Oncologist|February 14, 2013
Locoregional interaction of ixabepilone (ixempra) after breast cancer radiationVinita Takiar, Eric A Strom, Donald P Baumann, et al.
Annals of Diagnostic Pathology|May 30, 2018
Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancersMopei Wang, Li Liang, Xiudong Lei, et al.
Pharmacology & Therapeutics|February 9, 2017
Targeting TRK family proteins in cancerYekaterina B Khotskaya, Vijaykumar R Holla, Anna F Farago, et al.
Pageof 66